TW200718434A - Method for producing granular oral composition with oligosaccharide solution - Google Patents

Method for producing granular oral composition with oligosaccharide solution

Info

Publication number
TW200718434A
TW200718434A TW095117132A TW95117132A TW200718434A TW 200718434 A TW200718434 A TW 200718434A TW 095117132 A TW095117132 A TW 095117132A TW 95117132 A TW95117132 A TW 95117132A TW 200718434 A TW200718434 A TW 200718434A
Authority
TW
Taiwan
Prior art keywords
oral composition
oligosaccharide
oral
solution
oligosaccharide solution
Prior art date
Application number
TW095117132A
Other languages
English (en)
Chinese (zh)
Inventor
Setsu Ijichi
Mieko Matsuoka
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of TW200718434A publication Critical patent/TW200718434A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095117132A 2005-05-31 2006-05-15 Method for producing granular oral composition with oligosaccharide solution TW200718434A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005158628A JP2006335648A (ja) 2005-05-31 2005-05-31 オリゴ糖溶液を用いて粒状経口組成物を製造する方法

Publications (1)

Publication Number Publication Date
TW200718434A true TW200718434A (en) 2007-05-16

Family

ID=37481399

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095117132A TW200718434A (en) 2005-05-31 2006-05-15 Method for producing granular oral composition with oligosaccharide solution

Country Status (5)

Country Link
JP (1) JP2006335648A (enExample)
KR (1) KR20080011389A (enExample)
CN (1) CN1872342A (enExample)
TW (1) TW200718434A (enExample)
WO (1) WO2006129468A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4758974B2 (ja) * 2007-11-05 2011-08-31 旭化成ケミカルズ株式会社 酸性乳飲料
JP4600853B2 (ja) * 2007-12-21 2010-12-22 日本薬品開発株式会社 麦類若葉由来凝縮液含有物顆粒、顆粒およびその製造方法
JP5324943B2 (ja) * 2008-01-30 2013-10-23 サントリーホールディングス株式会社 流動層造粒による粒状食品組成物の製造方法
JP6523164B2 (ja) * 2013-04-26 2019-05-29 サントリーホールディングス株式会社 フラクトオリゴ糖とケルセチン配糖体とを含有する組成物
JP6910185B6 (ja) * 2017-04-13 2021-10-20 雄二 松川 副交感神経優位化リンパ球活性化抗腫瘍剤及びその製造方法
JP6910200B6 (ja) * 2017-05-12 2021-10-20 雄二 松川 上部消化管粘膜吸収による副交感神経優位化リンパ球活性化上部消化管粘膜吸収抗腫瘍剤
JP2019201629A (ja) * 2018-05-17 2019-11-28 大正製薬株式会社 固形物
JP7822312B2 (ja) * 2019-12-12 2026-03-02 ケンブリッジ グリコサイエンス エルティーディー 低糖の多相食料品
KR102364023B1 (ko) * 2021-04-29 2022-02-17 주식회사 셀로닉스 첨가물을 사용하지 않는 과립제형의 프락토올리고당 프리바이오틱스 제조방법
CN117462602B (zh) * 2023-12-27 2024-03-29 深圳保时健生物工程有限公司 一种益生菌复合剂及制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3505367B2 (ja) * 1997-09-10 2004-03-08 三菱化学フーズ株式会社 甘味料組成物
JP2000336354A (ja) * 1999-03-19 2000-12-05 Sanei Gen Ffi Inc 退色防止剤
JP2002218945A (ja) * 2001-01-25 2002-08-06 Toyo Shinyaku:Kk 食物繊維含有食品およびその成型方法ならびに成型方法に用いる結合剤
JP2005124587A (ja) * 2001-12-28 2005-05-19 Toyo Shinyaku:Kk ケール乾燥粉末の造粒物およびその製造方法
JP2005102639A (ja) * 2003-10-01 2005-04-21 Marutomo Co Ltd 便秘改善用食品およびその製造方法
JP2005295840A (ja) * 2004-04-08 2005-10-27 Yoshio Minamitani 健康こんにゃく

Also Published As

Publication number Publication date
JP2006335648A (ja) 2006-12-14
WO2006129468A1 (ja) 2006-12-07
CN1872342A (zh) 2006-12-06
KR20080011389A (ko) 2008-02-04

Similar Documents

Publication Publication Date Title
TN2009000093A1 (en) Pharmaceutical compositions comprising nilotinib or its salt
MX353962B (es) Carbono activado impregnado con acido y metodos para formar y utilizar el mismo.
SI1896364T1 (sl) Praĺ kasti apneni sestavek, postopek za proizvodnjo in uporaba le-tega
MX2009001294A (es) Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
WO2010003078A3 (en) Melt granulation process
PL2020864T3 (pl) Sprasowana guma do żucia i sposób jej wytwarzania
UA85157C2 (ru) Полиолефиновая пена, способ ее изготовления и применения
GB201021170D0 (en) Granulated organopolysiloxane products
MY147488A (en) Substituted 7-azaindazoles, compositions containing them, production process and use
TW200727791A (en) Materials and methods for improving livestock productivity
PL1881967T3 (pl) Podstawione benzo[d]izoksazol-3-iloaminy jako środki przeciwbólowe
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
ATE508782T1 (de) Psa-verfahren unter verwendung eines verbundstoffadsorptionsbettes mit einem adsorptionsmittel und pcm-agglomeraten
EP1928802B8 (de) In wasser redispergierbares pulver, verfahren zu dessen herstellung und dessen verwendung
TW200714392A (en) Silver-copper composite powder having silver microparticule attached thereto, and method of production of the silver-copper composite powder
TWI347960B (en) Process for the production of mouldings from a mixture of particulate natural materials and thermoplastic binder
FR2930265B1 (fr) Procede d'agglomeration de poussieres industrielles, en particulier par technique de briquetage
WO2007061938A3 (en) Systems and methods for liquid dosing
MX2009004557A (es) Composicion farmaceutica granulada seca y metodos para producirla.
SG149080A1 (en) Composition comprising a nsaid and paracetamol
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
ZA200307410B (en) Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent, salts of ranelic acid and their hydrates.
MY138852A (en) Fluid bed granulation process
MX2009013743A (es) Sistema y proceso para producir alcohol.
WO2008046172A3 (en) Additivated sodic bentonite for use in composition of green sand for molding of cast parts